Search | Page 13 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies

    ... through -2: 30 mg/m^2 IV daily Other Name: Fludara Drug: Cyclophosphamide Days -6 through -5: 14.5 mg/kg IV daily Other ...

    Clinical Trial last updated 05/03/2016 - 11:45am.

  2. Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies

    ... 6 days before transplant Fludarabine (chemotherapy) Cyclophosphamide (chemotherapy) 5 days before transplant Fludarabine Thiotepa 4 ... transplant Fludarabine 6 days before transplant Fludarabine Cyclophosphamide 5 days before transplant Fludarabine Cyclophosphamide 4 days ...

    Clinical Trial last updated 04/29/2016 - 1:33pm.

  3. HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

    ... Thiotepa 5 mg/kg/day x 2 or 10 mg/kg/day x 1 Drug: Cyclophosphamide 60 mg/ kg/day x 2 (or fludarabine 25mg/m2 x 5 if cyclophosphamide is contraindicated). Drug: Busulfan 0.8 mg/kg every ...

    Clinical Trial last updated 04/29/2016 - 3:18pm.

  4. Clinical Trials Report for December 2015

    ... malignancies. Giving low doses of chemotherapy, such as cyclophosphamide and fludarabine phosphate, before a donor stem ...

    Page last updated 11/30/2015 - 10:31am.

  5. Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia

    ... Intervention:  Drug: Cyclophosphamide,Campath IH and TBI DAY 5 TREATMENT 6 5 CYTOXAN 50 ...

    Clinical Trial last updated 04/26/2016 - 10:05am.

  6. Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

    ... infusion over 30 minutes, daily On days -6, -5, -4, and -3 Cyclophosphamide:1200 mg/m2 per day IV infusion over 2 hours on Days 6, -5, -4, ... day continuous IV infusion over 24 hours daily on days 1-4 Cyclophosphamide: 750 mg/m2 IV infusion over 30 minutes on day 5 Prednisone:60 ...

    Clinical Trial last updated 04/29/2016 - 1:00pm.

  7. Immunosuppression and Stem Cell Transplantation – How Are These Treatments Chosen?

    ... cyclosporine , or tacrolimus, and sometimes high dose cyclophosphamide .  These aren’t cures, and we don’t anticipate in an ...

    Interview last updated 07/15/2015 - 10:19am.

  8. Clinical Trials Report for September 2015

    ... non-myeloablative conditioning and post transplantation cyclophosphamide with partially HLA -mismatched donors. This ...

    Page last updated 08/26/2015 - 1:05pm.

  9. Clinical Trials Report for August 2015

    ... non-myeloablative conditioning and post transplantation cyclophosphamide with partially HLA -mismatched donors. This ...

    Page last updated 07/30/2015 - 8:45am.

  10. Clinical Trials Report for April 2014

    ... identifier: NCT01900119 Post Transplant Cyclophosphamide Cytoxan) for GvHD Prophylaxis The main purpose of this study is to assess the effects of cyclophosphamide (cytoxan) in the post transplant setting to prevent onset of ...

    Page last updated 04/18/2014 - 3:36pm.